904 related articles for article (PubMed ID: 36209270)
1. Signaling pathways and therapeutic interventions in gastric cancer.
Lei ZN; Teng QX; Tian Q; Chen W; Xie Y; Wu K; Zeng Q; Zeng L; Pan Y; Chen ZS; He Y
Signal Transduct Target Ther; 2022 Oct; 7(1):358. PubMed ID: 36209270
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.
Riquelme I; Saavedra K; Espinoza JA; Weber H; García P; Nervi B; Garrido M; Corvalán AH; Roa JC; Bizama C
Oncotarget; 2015 Sep; 6(28):24750-79. PubMed ID: 26267324
[TBL] [Abstract][Full Text] [Related]
3. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
4. The Correlation between EGFR and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer.
Fard SS; Saliminejad K; Sotoudeh M; Soleimanifard N; Kouchaki S; Yazdanbod M; Mahmoodzadeh H; Ghavamzadeh A; Malekzadeh R; Chahardouli B; Alimoghaddam K; Ghaffari SH
Anticancer Agents Med Chem; 2019; 19(17):2097-2107. PubMed ID: 31566139
[TBL] [Abstract][Full Text] [Related]
5. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Epigenetic Associated Genes with Differential Gene Expression and Prognosis in Gastric Cancer.
An S; Li X; Li B; Li Y
Comb Chem High Throughput Screen; 2023; 26(3):527-538. PubMed ID: 35570548
[TBL] [Abstract][Full Text] [Related]
7. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
8. Molecular biomarkers in gastric cancer.
Elimova E; Wadhwa R; Shiozaki H; Sudo K; Estrella JS; Badgwell BD; Das P; Matamoros A; Song S; Ajani JA
J Natl Compr Canc Netw; 2015 Apr; 13(4):e19-29. PubMed ID: 26052595
[TBL] [Abstract][Full Text] [Related]
9. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
[TBL] [Abstract][Full Text] [Related]
10. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets.
Ouyang J; Long Z; Li G
Biomed Res Int; 2020; 2020():2790679. PubMed ID: 32685459
[TBL] [Abstract][Full Text] [Related]
15. Iroquois Family Genes in Gastric Carcinogenesis: A Comprehensive Review.
Dos Santos EC; Petrone I; Binato R; Abdelhay E
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980893
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic mechanisms in gastric cancer.
Shi J; Qu YP; Hou P
World J Gastroenterol; 2014 Oct; 20(38):13804-19. PubMed ID: 25320518
[TBL] [Abstract][Full Text] [Related]
18. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K/AKT and MAPK/ERK signaling pathways in gastric cancer.
Li JF; Li WH; Xue LL; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):588-597. PubMed ID: 30720166
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of LINC02465 Suppresses Gastric Cancer Cell Growth and Metastasis Via PI3K/AKT Pathway.
Han L; Hao Y; Wang J; Wang Z; Yang H; Wu X
Hum Gene Ther Clin Dev; 2019 Mar; 30(1):19-28. PubMed ID: 30632400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
